187 related articles for article (PubMed ID: 36336278)
1. Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine.
Kolli AR; Calvino-Martin F; Kuczaj AK; Wong ET; Titz B; Xiang Y; Lebrun S; Schlage WK; Vanscheeuwijck P; Hoeng J
Eur J Pharm Sci; 2023 Jan; 180():106321. PubMed ID: 36336278
[TBL] [Abstract][Full Text] [Related]
2. Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for toxicological assessment: nicotine delivery systems and beyond.
Kolli AR; Kuczaj AK; Martin F; Hayes AW; Peitsch MC; Hoeng J
Crit Rev Toxicol; 2019 Oct; 49(9):725-741. PubMed ID: 31903848
[TBL] [Abstract][Full Text] [Related]
3. Fractional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7- micro m fluorescein aerosols.
Sakagami M; Kinoshita W; Sakon K; Makino Y
Arch Toxicol; 2003 Jun; 77(6):321-9. PubMed ID: 12799771
[TBL] [Abstract][Full Text] [Related]
4. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
Martin AR; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery and spatiotemporal tissue distribution of hydroxychloroquine in rat lung.
Xia W; Kolli AR; Kuczaj AK; Szostak J; Lam S; Toh WW; Purwanti A; Tan WT; Ng R; Phillips B; Peitsch MC; Hoeng J
Eur J Pharm Sci; 2024 Mar; 194():106693. PubMed ID: 38184016
[TBL] [Abstract][Full Text] [Related]
6. Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model.
Ladumor MK; Unadkat JD
Drug Metab Dispos; 2022 May; 50(5):519-528. PubMed ID: 35246463
[TBL] [Abstract][Full Text] [Related]
7. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
[TBL] [Abstract][Full Text] [Related]
8. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
[TBL] [Abstract][Full Text] [Related]
9. Simulated pharmacokinetics of inhaled caffeine and melatonin from existing products indicate the lack of dosimetric considerations.
Kolli AR; Kuczaj AK; Calvino-Martin F; Hoeng J
Food Chem Toxicol; 2024 May; 187():114601. PubMed ID: 38493979
[TBL] [Abstract][Full Text] [Related]
10. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.
Boger E; Fridén M
J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860
[TBL] [Abstract][Full Text] [Related]
11. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
Martin AR; Moore CP; Finlay WH
Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption.
Miller NA; Graves RH; Edwards CD; Amour A; Taylor E; Robb O; O'Brien B; Patel A; Harrell AW; Hessel EM
Clin Pharmacokinet; 2022 Feb; 61(2):281-293. PubMed ID: 34458976
[TBL] [Abstract][Full Text] [Related]
13. Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling.
Campbell J; Franzen A; Van Landingham C; Lumpkin M; Crowell S; Meredith C; Loccisano A; Gentry R; Clewell H
Inhal Toxicol; 2016 Sep; 28(11):520-35. PubMed ID: 27569524
[TBL] [Abstract][Full Text] [Related]
14. Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.
Shao XM; Liu S; Lee ES; Fung D; Pei H; Liang J; Mudgway R; Zhang J; Feldman JL; Zhu Y; Louie S; Xie XS
J Appl Physiol (1985); 2018 Nov; 125(5):1555-1562. PubMed ID: 30236046
[TBL] [Abstract][Full Text] [Related]
15. New Approach Methodology for Assessing Inhalation Risks of a Contact Respiratory Cytotoxicant: Computational Fluid Dynamics-Based Aerosol Dosimetry Modeling for Cross-Species and In Vitro Comparisons.
Corley RA; Kuprat AP; Suffield SR; Kabilan S; Hinderliter PM; Yugulis K; Ramanarayanan TS
Toxicol Sci; 2021 Aug; 182(2):243-259. PubMed ID: 34077545
[TBL] [Abstract][Full Text] [Related]
16. Aerosol deposition modeling using ACSL.
Carpenter RL
Drug Chem Toxicol; 1999 Feb; 22(1):73-90. PubMed ID: 10189572
[TBL] [Abstract][Full Text] [Related]
17. Respirable aerosol exposures of nicotine dry powder formulations to
Sciuscio D; Hoeng J; Peitsch MC; Vanscheeuwijck P
Inhal Toxicol; 2019 May; 31(6):248-257. PubMed ID: 31496314
[No Abstract] [Full Text] [Related]
18. A revision of the multiple-path particle dosimetry model focusing on tobacco product aerosol dynamics.
Mori A; Ito S; Sekine T
Int J Numer Method Biomed Eng; 2024 Mar; 40(3):e3796. PubMed ID: 38185887
[TBL] [Abstract][Full Text] [Related]
19. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.
Ahmed A; Prime D; Burnell PK; Högger P
J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):169-78. PubMed ID: 22280010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
